Joseph P Hagan Regulus Therapeutics Inc. (RGLS) insider trading activity

Joseph P Hagan is Chief Executive Officer of Regulus Therapeutics Inc.. Currently has a direct ownership of 57,112 shares of RGLS, which is worth approximately $87,952. The most recent transaction as insider was on Jan 18, 2024, when has been sold 14,580 shares (Common Stock) at a price of $1.19 per share, resulting in proceeds of $17,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.1K

0% 3M change

86.3% 12M change

Total Value Held $87,952

Joseph P Hagan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 18 2024	SELL Open market or private sale	$17,350 $1.19 p/Share	14,580 Reduced 20.34%	57,112 Common Stock
Jan 12 2024	BUY Grant, award, or other acquisition	-	30,000 Added 29.5%	71,692 Common Stock
Jan 26 2022	BUY Open market or private purchase	$22,000 $0.22 p/Share	100,000 Added 19.34%	417,006 Common Stock
May 17 2021	SELL Open market or private sale	$3,726 $0.89 p/Share	4,186 Reduced 1.31%	316,292 Common Stock
Apr 14 2021	BUY Conversion of derivative security	-	75,850 Added 19.14%	320,478 Common Stock
Feb 16 2021	SELL Open market or private sale	$7,128 $1.72 p/Share	4,144 Reduced 0.85%	485,756 Common Stock
Nov 16 2020	SELL Open market or private sale	$3,169 $0.52 p/Share	6,094 Reduced 2.74%	215,994 Common Stock

Also insider at

ZSANQ

Zosano Pharma Corp

Director

AUPH

Aurinia Pharmaceuticals Inc. Healthcare

Director

JPH

Joseph P Hagan

Chief Executive Officer

Victoria, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Value

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Regulus Therapeutics Inc.

Track Activities on RGLS

Account